Miyasaki Yoko, Rabenstein John D, Rhea Joshua, Crouch Marie-Laure, Mocek Ulla M, Kittell Patricia Emmett, Morgan Margie A, Nichols Wesley Stephen, Van Benschoten M M, Hardy William David, Liu George Y Isolation and Characterization of Antimicrobial Compounds in Plant Extracts against Multidrug-Resistant Acinetobacter baumannii PloS one, 2013; 8(4): e61594.
Wasmuth Jan-Christian, Rockstroh JÃ¼rgen Kurt, Hardy William David Drug safety evaluation of maraviroc for the treatment of HIV infection Expert opinion on drug safety, 2012; 11(1): 161-74.
Miyasaki Yoko, Nichols W Stephen, Morgan Margie A, Kwan Jamie A, Van Benschoten M M, Kittell Patricia Emmett, Hardy W David Screening of herbal extracts against multi-drug resistant Acinetobacter baumannii Phytotherapy research : PTR, 2010; 24(8): 1202-6.
Hardy W David, Gulick Roy M, Mayer Howard, Fätkenheuer Gerd, Nelson Mark, Heera Jayvant, Rajicic Natasa, Goodrich James Two-Year Safety and Virologic Efficacy of Maraviroc in Treatment-Experienced Patients With CCR5-Tropic HIV-1 Infection: 96-Week Combined Analysis of MOTIVATE 1 and 2 Journal of acquired immune deficiency syndromes (1999), 2010; .
Holland Gary N, Vaudaux Jean D, Jeng Samuel M, Yu Fei, Goldenberg David T, Folz Ina-Caren, Cumberland William G, McCannel Colin A, Helm Craig J, Hardy W David, Hardy W David Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994) American journal of ophthalmology, 2008; 145(1): 5-11.
Rockstroh Jürgen Kurt, Hardy W David Antiretroviral therapy in coinfected patients: viral hepatitis and tuberculosis Current opinion in HIV and AIDS, 2006; 1(5): 442-8.
Javaly K, Wohlfeiler M, Kalayjian R, Klein T, Bryson Y, Grafford K, Martin-Munley S, Hardy W D Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study Journal of acquired immune deficiency syndromes (1999), 1999; 21(4): 301-6.
Freedberg K A, Hardy W D, Holzman R S, Tosteson A N, Craven D E Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients Medical decision making : an international journal of the Society for Medical Decision Making, 1996; 16(1): 29-35.
Hardy W D, Feinberg J, Finkelstein D M, Power M E, He W, Kaczka C, Frame P T, Holmes M, Waskin H, Fass R J A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021 The New England journal of medicine, 1992; 327(26): 1842-8.
Hardy W D Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial The American journal of medicine, 1992; 92(2A): 30S-35S.
Hardy W D Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients Journal of acquired immune deficiency syndromes, 1991; 4 Suppl 1(6): S22-8.
Does this profile need updating? Contact Us